Literature DB >> 33110233

Small extracellular vesicles containing miR-30a-3p attenuate the migration and invasion of hepatocellular carcinoma by targeting SNAP23 gene.

Chengdong Liu1, Xiaohan Zhou2, Qian Long1, Hanyi Zeng1, Qingcan Sun1, Yuting Chen2, Dehua Wu3, Li Liu4.   

Abstract

Cancer cells under hypoxic, endoplasmic reticulum, and reactive oxygen species stress secrete copious amounts of small extracellular vesicles (sEVs) to promote tumor metastasis. The effects of blocking stress-induced sEV release on tumor metastasis remain unknown. We found that miR-30a-3p was selectively sorted into sEVs by hepatocellular carcinoma (HCC) cells under the influence of multiple stressors. miR-30a-3p removal from cancer cells through sEVs promoted HCC cell migration and invasion, whereas exogenous overexpression of miR-30a-3p could inhibit migration, invasion, and sEV release by directly targeting SNAP23. HCC cells efficiently absorbed hepatic stellate cell (HSC) sEVs, providing an advantage in the treatment of HCC using HSC sEVs. Treatment with HSC sEVs rich in miR-30a-3p cargo effectively attenuated HCC migration, invasion, and metastasis. Overall, sEVs containing miR-30a-3p decreased sEV secretion as well as the migration, invasion, and metastasis of HCC by directly targeting SNAP23, thereby providing an effective strategy to attenuate metastasis of HCC.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33110233     DOI: 10.1038/s41388-020-01521-7

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  40 in total

1.  [Indices of the clearance of endogenous creatinine, urea and uric acid in patients with arterial hypertension].

Authors:  M Lazarow
Journal:  Pol Tyg Lek       Date:  1969-03-24

2.  [Stress tolerance of surgical patients from the viewpoint of internal medicine].

Authors:  P Schölmerich
Journal:  Langenbecks Arch Chir       Date:  1984

Review 3.  Exosomes and other extracellular vesicles in oral and salivary gland cancers.

Authors:  Chaoning Zhan; Xiaojun Yang; Xuemin Yin; Jin Hou
Journal:  Oral Dis       Date:  2019-08-29       Impact factor: 3.511

4.  Patient specific outcomes of charged particle therapy for hepatocellular carcinoma - A systematic review and quantitative analysis.

Authors:  Piotr Spychalski; Jarek Kobiela; Magdalena Antoszewska; Agata Błażyńska-Spychalska; Barbara A Jereczek-Fossa; Morten Høyer
Journal:  Radiother Oncol       Date:  2019-01-02       Impact factor: 6.280

5.  Cancer-derived exosomal miR-221-3p promotes angiogenesis by targeting THBS2 in cervical squamous cell carcinoma.

Authors:  Xiang-Guang Wu; Chen-Fei Zhou; Yan-Mei Zhang; Rui-Ming Yan; Wen-Fei Wei; Xiao-Jing Chen; Hong-Yan Yi; Luo-Jiao Liang; Liang-Sheng Fan; Li Liang; Sha Wu; Wei Wang
Journal:  Angiogenesis       Date:  2019-04-15       Impact factor: 9.596

6.  MVP-mediated exosomal sorting of miR-193a promotes colon cancer progression.

Authors:  Yun Teng; Yi Ren; Xin Hu; Jingyao Mu; Abhilash Samykutty; Xiaoying Zhuang; Zhongbin Deng; Anil Kumar; Lifeng Zhang; Michael L Merchant; Jun Yan; Donald M Miller; Huang-Ge Zhang
Journal:  Nat Commun       Date:  2017-02-17       Impact factor: 14.919

7.  Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis.

Authors:  Zhicheng Zeng; Yuling Li; Yangjian Pan; Xiaoliang Lan; Fuyao Song; Jingbo Sun; Kun Zhou; Xiaolong Liu; Xiaoli Ren; Feifei Wang; Jinlong Hu; Xiaohui Zhu; Wei Yang; Wenting Liao; Guoxin Li; Yanqing Ding; Li Liang
Journal:  Nat Commun       Date:  2018-12-19       Impact factor: 14.919

8.  FGG promotes migration and invasion in hepatocellular carcinoma cells through activating epithelial to mesenchymal transition.

Authors:  Xiang Zhang; Fei Wang; Yanbing Huang; Kun Ke; Bixing Zhao; Lihong Chen; Naishun Liao; Lei Wang; Qin Li; Xiaolong Liu; Yingchao Wang; Jingfeng Liu
Journal:  Cancer Manag Res       Date:  2019-02-19       Impact factor: 3.989

9.  Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT.

Authors:  Xina Zhang; Buqing Sai; Fan Wang; Lujuan Wang; Yuhui Wang; Leliang Zheng; Guiyuan Li; Jingqun Tang; Juanjuan Xiang
Journal:  Mol Cancer       Date:  2019-03-13       Impact factor: 27.401

Review 10.  The role of exosomal noncoding RNAs in cancer.

Authors:  Yan Xie; Wei Dang; Siwei Zhang; Wenxing Yue; Li Yang; Xingyu Zhai; Qijia Yan; Jianhong Lu
Journal:  Mol Cancer       Date:  2019-03-09       Impact factor: 27.401

View more
  13 in total

Review 1.  RNA splicing: a dual-edged sword for hepatocellular carcinoma.

Authors:  Anjali Kashyap; Greesham Tripathi; Avantika Tripathi; Rashmi Rao; Manju Kashyap; Anjali Bhat; Deepak Kumar; Anjali Rajhans; Pravindra Kumar; Darshan Shimoga Chandrashekar; Riaz Mahmood; Amjad Husain; Hatem Zayed; Alok Chandra Bharti; Manoj Kumar Kashyap
Journal:  Med Oncol       Date:  2022-08-16       Impact factor: 3.738

Review 2.  Roles of small extracellular vesicles in the development, diagnosis and possible treatment strategies for hepatocellular carcinoma (Review).

Authors:  Shuyue Yang; Jiaxin Wang; Shidong Wang; Anni Zhou; Guiping Zhao; Peng Li
Journal:  Int J Oncol       Date:  2022-06-08       Impact factor: 5.884

3.  Identification of a thirteen-gene signature predicting overall survival for hepatocellular carcinoma.

Authors:  Xiaohan Zhou; Chengdong Liu; Hanyi Zeng; Dehua Wu; Li Liu
Journal:  Biosci Rep       Date:  2021-04-30       Impact factor: 3.840

4.  A bioinformatic analysis: the overexpression and clinical significance of FCGBP in ovarian cancer.

Authors:  Kai Wang; Chenan Guan; Xianwen Shang; Xiang Ying; Shuangshuang Mei; Hanxiao Zhu; Liang Xia; Zeying Chai
Journal:  Aging (Albany NY)       Date:  2021-03-03       Impact factor: 5.682

5.  Pan-cancer analysis identifies FAM49B as an immune-related prognostic maker for hepatocellular carcinoma.

Authors:  Feng Xu; Jionghuang Chen; Dihua Huang
Journal:  J Cancer       Date:  2022-01-01       Impact factor: 4.207

Review 6.  Biomarkers for hepatocellular carcinoma based on body fluids and feces.

Authors:  Ming-Cheng Guan; Wei Ouyang; Ming-Da Wang; Lei Liang; Na Li; Ting-Ting Fu; Feng Shen; Wan-Yee Lau; Qiu-Ran Xu; Dong-Sheng Huang; Hong Zhu; Tian Yang
Journal:  World J Gastrointest Oncol       Date:  2021-05-15

7.  CCDC137 Is a Prognostic Biomarker and Correlates With Immunosuppressive Tumor Microenvironment Based on Pan-Cancer Analysis.

Authors:  Lihao Guo; Boxin Li; Zhaohong Lu; Hairong Liang; Hui Yang; Yuting Chen; Shiheng Zhu; Minjuan Zeng; Yixian Wei; Tonggong Liu; Tikeng Jiang; Mei Xuan; Huanwen Tang
Journal:  Front Mol Biosci       Date:  2021-05-13

8.  Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles.

Authors:  Aixue Li; Yunan Zhao; Yixiu Li; Liangdi Jiang; Yongwei Gu; Jiyong Liu
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

Review 9.  Anti-Cancer Role and Therapeutic Potential of Extracellular Vesicles.

Authors:  Naoomi Tominaga
Journal:  Cancers (Basel)       Date:  2021-12-15       Impact factor: 6.639

10.  miR-150-5p-Containing Extracellular Vesicles Are a New Immunoregulator That Favor the Progression of Lung Cancer in Hypoxic Microenvironments by Altering the Phenotype of NK Cells.

Authors:  Wei-An Chang; Ming-Ju Tsai; Jen-Yu Hung; Kuan-Li Wu; Ying-Ming Tsai; Yung-Chi Huang; Chao-Yuan Chang; Pei-Hsun Tsai; Ya-Ling Hsu
Journal:  Cancers (Basel)       Date:  2021-12-13       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.